共 54 条
T-Type Ca2+ Channel Inhibition Induces p53-Dependent Cell Growth Arrest and Apoptosis through Activation of p38-MAPK in Colon Cancer Cells
被引:52
作者:
Dziegielewska, Barbara
[1
]
Brautigan, David L.
[2
,3
]
Larner, James M.
[1
,3
]
Dziegielewski, Jaroslaw
[1
,3
]
机构:
[1] Univ Virginia, Sch Med, Ctr Cell Signaling, Dept Radiat Oncol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Sch Med, Ctr Cell Signaling, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA
[3] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA
关键词:
CALCIUM-CHANNELS;
PROTEIN-KINASE;
P53;
PHOSPHORYLATION;
GLIOBLASTOMA;
MIBEFRADIL;
EXPRESSION;
INACTIVATION;
PATHWAYS;
SURVIVAL;
D O I:
10.1158/1541-7786.MCR-13-0485
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Epithelial tumor cells express T-type Ca2+ channels, which are thought to promote cell proliferation. This study investigated the cellular response to T-type Ca2+ channel inhibition either by small-molecule antagonists or by RNAi-mediated knockdown. Selective T-type Ca2+ channel antagonists caused growth inhibition and apoptosis more effectively in HCT116 cells expressing wild-type p53 (p53wt), than in HCT116 mutant p53(-/-) cells. These antagonists increased p53-dependent gene expression and increased genomic occupancy of p53 at specific target sequences. The knockdown of a single T-type Ca2+ channel subunit (CACNA1G) reduced cell growth and induced caspase-3/7 activation in HCT116 p53wt cells as compared with HCT116 mutant p53(-/-) cells. Moreover, CaCo2 cells that do not express functional p53 were made more sensitive to CACNA1G knockdown when p53wt was stably expressed. Upon T-type Ca2+ channel inhibition, p38-MAPK promoted phosphorylation at Ser392 of p53wt. Cells treated with the inhibitor SB203580 or specific RNAi targeting p38-MAPK alpha/beta (MAPK14/MAPK11) showed resistance to T-type Ca2+ channel inhibition. Finally, the decreased sensitivity to channel inhibition was associated with decreased accumulation of p53 and decreased expression of p53 target genes, p21Cip1 (CDKN1A) and BCL2-binding component 3 (BBC3/PUMA). (C)2013 AACR.
引用
收藏
页码:348 / 358
页数:11
相关论文